Long-acting injectable PrEP may offer an alternative to daily medication

People with controlled HIV are not thought to be at increased risk, and there is no shortage of HIV medication, BHIVA says.

General HPV screening at age 19 showed vaccination of both genders prevented HPV infections much more effectively than vaccination of girls only.

Clinicians advised to stick with 12-week standard course

PrEP will be routinely available across England as part of Government efforts to end HIV transmission by 2030.

Test offers promising future for boosting PrEP adherence

Phase 3 data highlight promising new regimen

Chinese data highlight value of isolation and containment

CROI 2020 – Clear association but overall clinical implications are unknown

CROI 2020 – Monitor regularly and consider appropriate interventions

More data are needed.

Mental health is ‘the missing link’ and ‘the elephant in the room’ in drive to meet target of zero infections by 2020, say MPs

The research illustrates the significant intermediate and long-term cost of HPV vaccine hesitancy, which WHO has identified as a key health threat.

Despite the disappointment, ‘kick and kill’ is not dead and the study has important lessons for HIV research.